← All companies
Adaptive Biotechnologies Corp
ADPT - CIK 0001478320
Market cap$3.05 B
Rank#1800
SEC filings764
The table below shows Adaptive Biotechnologies Corp's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $70.50M | $47.92M | $65.06M | $90.03M | $139.06M | $123.44M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $50.37M | $41.73M | $37.97M | $40.06M | $17.41M | $10.05M |
| Inventory | $9.82M | $8.44M | $14.45M | $14.45M | $19.26M | $14.06M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.